High-dose immunoglobulin for juvenile myasthenia gravis.
A four-year-old girl with the ocular type of myasthenia gravis was effectively treated with intravenous high dose human immunoglobulin. Since conventional anti-choline-esterase drugs failed to induce a satisfactory outcome and the patient continued to suffer from amblyopia, high-dose immunoglobulin was tried according to the method of Gados. Subsequently, she became asymptomatic and her anti-acetylcholine-receptor antibody titer decreased gradually to normal. Currently, she is six years old and continues to be free from complaints and on no medication.
Maruyama
Y
Y
Takeshita
S
S
Sekine
I
I
Yoshioka
S
S
D001763:Blepharoptosis / Q000209:etiology; D002675:Child, Preschool; D005260:Female; D006801:Humans; D007116:Immunization, Passive; D009157:Myasthenia Gravis / Q000628:therapy*